Investor's Calendar

June 2023

Mon Tue Wed Thu Fri Sat Sun
29
30
31
1
2
3
4
 
 
 
 
 
 
 
5
6
7
8
9
10
11
 
 
 
 
 
 
 
12
13
14
15
16
17
18
 
 
 
 
 
 
 
19
20
21
22
23
24
25
 
 
 
 
 
 
 
26
27
28
29
30
1
2
 
 
 
 
 
 
 

Last News

First quarter 2023 results press release
ROVI reached 201.9 million euros of revenue in the first post-pandemic quarter
3 min
10 May, 2023
ROVI commences clinical development of a new three-monthly formulation of Letrozole (...
The objective of the new three-monthly formulation is to reach bioequivalence in the plasma levels of...
6 min
25 Apr, 2023
Created a Chair to study the psychological impact and benefits of technology in mental...
The objective is to help improve society’s mental health and take advantage of the opportunities the new...
3 min
12 Apr, 2023

See more

Financial and Business Information

Information for investors

Marta Campos

Marta Campos

Head of Investor Relations

mcampos@rovi.es

Antonio Marquina

Antonio Marquina

Investor Relations

amarquina@rovi.es

buzón general Rovi

General Email

ir@rovi.es